Clinical Trials Browser

Phase 2 × Auranofin × Clear all

NCT03456700 2025-05-08

Auranofin and Sirolimus in Treating Participants With Ovarian Cancer

Phase 2 Terminated

22 enrolled 9 charts

Ovarian Neoplasms

NCT01419691 2016-01-18

Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)

Phase 2 Completed

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic